|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
10.78(B) |
Last
Volume: |
176,534 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Chubb Stephen D |
Director |
|
2016-02-23 |
4 |
OE |
$28.29 |
$295,348 |
D/D |
10,440 |
21,944 |
|
- |
|
Milne George M Jr |
Director |
|
2016-02-23 |
4 |
S |
$73.00 |
$762,319 |
D/D |
(10,440) |
27,760 |
|
- |
|
Milne George M Jr |
Director |
|
2016-02-23 |
4 |
OE |
$28.29 |
$295,348 |
D/D |
10,440 |
38,200 |
|
- |
|
Ackerman Thomas F |
Senior Financial Advisor |
|
2016-02-22 |
4 |
D |
$73.31 |
$42,080 |
D/D |
(574) |
111,124 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2016-02-22 |
4 |
D |
$73.31 |
$53,076 |
D/D |
(724) |
56,208 |
|
- |
|
Gillett Nancy |
Corporate Executive VP |
|
2016-02-22 |
4 |
D |
$73.31 |
$50,364 |
D/D |
(687) |
24,705 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2016-02-22 |
4 |
D |
$73.31 |
$59,748 |
D/D |
(815) |
157,325 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2016-02-22 |
4 |
D |
$73.31 |
$210,106 |
D/D |
(2,866) |
378,319 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2016-02-22 |
4 |
AS |
$73.66 |
$202,847 |
D/D |
(2,738) |
381,185 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2016-02-22 |
4 |
AS |
$73.23 |
$675,740 |
D/D |
(9,210) |
383,923 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2016-02-22 |
4 |
AS |
$72.89 |
$718,830 |
D/D |
(9,831) |
393,133 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2016-02-22 |
4 |
OE |
$40.40 |
$879,872 |
D/D |
21,779 |
402,964 |
|
- |
|
Ackerman Thomas F |
Senior Financial Advisor |
|
2016-02-16 |
4 |
AS |
$73.72 |
$454,568 |
D/D |
(6,152) |
113,898 |
|
- |
|
Ackerman Thomas F |
Senior Financial Advisor |
|
2016-02-16 |
4 |
AS |
$74.21 |
$163,605 |
D/D |
(2,200) |
111,698 |
|
- |
|
Ackerman Thomas F |
Senior Financial Advisor |
|
2016-02-16 |
4 |
AS |
$72.67 |
$356,713 |
D/D |
(4,859) |
120,050 |
|
- |
|
Ackerman Thomas F |
Senior Financial Advisor |
|
2016-02-16 |
4 |
OE |
$37.03 |
$518,559 |
D/D |
13,211 |
124,909 |
|
- |
|
Gillett Nancy |
Corporate Executive VP |
|
2016-02-12 |
4 |
S |
$71.90 |
$485,325 |
D/D |
(6,750) |
25,392 |
|
- |
|
Reese C Richard |
Director |
|
2016-02-12 |
4 |
S |
$71.48 |
$302,238 |
D/D |
(4,228) |
31,123 |
|
- |
|
Reese C Richard |
Director |
|
2016-02-12 |
4 |
OE |
$28.39 |
$296,392 |
D/D |
10,440 |
35,351 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2016-02-10 |
4 |
D |
$68.16 |
$626,595 |
D/D |
(9,193) |
158,140 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2016-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,031 |
167,333 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2016-02-10 |
4 |
D |
$68.16 |
$541,190 |
D/D |
(7,940) |
56,932 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2016-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
21,362 |
64,872 |
|
- |
|
Gillett Nancy |
Corporate Executive VP |
|
2016-02-10 |
4 |
D |
$68.16 |
$506,429 |
D/D |
(7,430) |
32,142 |
|
- |
|
Gillett Nancy |
Corporate Executive VP |
|
2016-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
21,362 |
39,572 |
|
- |
|
1200 Records found
|
|
Page 41 of 48 |
|
|